Orgenesis Inc. Operating Income

Operating Income of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.


Highlights and Quick Summary

  • Operating Income for the quarter ending September 29, 2021 was $-7.66 Million (a 229.29% increase compared to previous quarter)
  • Year-over-year quarterly Operating Income decreased by -85.54%
  • Annual Operating Income for 2020 was $-95.8 Million (a 335.86% increase from previous year)
  • Annual Operating Income for 2019 was $-22 Million (a 30.17% increase from previous year)
  • Annual Operating Income for 2018 was $-16.9 Million (a 15.24% increase from previous year)
  • Twelve month Operating Income ending September 29, 2021 was $-62.8 Million (a -2.62% decrease compared to previous quarter)
  • Twelve month trailing Operating Income decreased by -34.4% year-over-year
Trailing Operating Income for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$-62.8 Million $-64.5 Million $-89 Million $-95.8 Million
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of Orgenesis Inc.

Most recent Operating Incomeof ORGS including historical data for past 10 years.

Interactive Chart of Operating Income of Orgenesis Inc.

Orgenesis Inc. Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-7.66 $-2.33 $0.08
2020 $-52.93 $-9.35 $-26.77 $-6.73 $-95.78
2019 $-5.06 $-3.78 $-4.85 $-8.28 $-21.98
2018 $-10.24 $-0.65 $-2.76 $-3.24 $-16.88
2017 $-3.41 $-2.32 $-2.65 $-3.45 $-11.23
2016 $-1.67 $-2.44 $-2.65 $-3.97 $-3.49 $-11.4
2015 $-7.21
2014 $-4.58
2013 $-5.46
2012 $-2.67
2011 $-2.68

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.